135 related articles for article (PubMed ID: 11424180)
1. Gender difference in DNA adduct levels among nonsmoking lung cancer patients.
Cheng YW; Hsieh LL; Lin PP; Chen CP; Chen CY; Lin TS; Su JM; Lee H
Environ Mol Mutagen; 2001; 37(4):304-10. PubMed ID: 11424180
[TBL] [Abstract][Full Text] [Related]
2. BPDE-like DNA adduct level in oral tissue may act as a risk biomarker of oral cancer.
Chuang CY; Tung JN; Su MC; Wu BC; Hsin CH; Chen YJ; Yeh KT; Lee H; Cheng YW
Arch Oral Biol; 2013 Jan; 58(1):102-9. PubMed ID: 22809837
[TBL] [Abstract][Full Text] [Related]
3. Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism.
Rojas M; Cascorbi I; Alexandrov K; Kriek E; Auburtin G; Mayer L; Kopp-Schneider A; Roots I; Bartsch H
Carcinogenesis; 2000 Jan; 21(1):35-41. PubMed ID: 10607731
[TBL] [Abstract][Full Text] [Related]
4. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes.
Rojas M; Alexandrov K; Cascorbi I; Brockmöller J; Likhachev A; Pozharisski K; Bouvier G; Auburtin G; Mayer L; Kopp-Schneider A; Roots I; Bartsch H
Pharmacogenetics; 1998 Apr; 8(2):109-18. PubMed ID: 10022748
[TBL] [Abstract][Full Text] [Related]
5. An association between BPDE-like DNA adduct levels and CYP1A1 and GSTM1 polymorphisma in pterygium.
Tung JN; Wu HH; Chiang CC; Tsai YY; Chou MC; Lee H; Cheng YW
Mol Vis; 2010 Apr; 16():623-9. PubMed ID: 20700368
[TBL] [Abstract][Full Text] [Related]
6. [Effects of CYP1A1 and GSTM1 gene polymorphisms and BPDE-DNA adducts on lung cancer].
Chen CM; Jin YT; Xu HY; Zhang CY; Zhang H; Zhang WM; Tan C; Sun XY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Feb; 29(1):23-7. PubMed ID: 22311486
[TBL] [Abstract][Full Text] [Related]
7. Benzo(a)pyrene diolepoxide (BPDE)-DNA adduct levels in leukocytes of smokers in relation to polymorphism of CYP1A1, GSTM1, GSTP1, GSTT1, and mEH.
Lodovici M; Luceri C; Guglielmi F; Bacci C; Akpan V; Fonnesu ML; Boddi V; Dolara P
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1342-8. PubMed ID: 15298956
[TBL] [Abstract][Full Text] [Related]
8. Genetic cancer susceptibility and DNA adducts: studies in smokers, tobacco chewers, and coke oven workers.
Bartsch H; Rojas M; Nair U; Nair J; Alexandrov K
Cancer Detect Prev; 1999; 23(6):445-53. PubMed ID: 10571654
[TBL] [Abstract][Full Text] [Related]
9. Induction of CYP1A1 and CYP1B1 and formation of carcinogen-DNA adducts in normal human mammary epithelial cells treated with benzo[a]pyrene.
Keshava C; Divi RL; Whipkey DL; Frye BL; McCanlies E; Kuo M; Poirier MC; Weston A
Cancer Lett; 2005 Apr; 221(2):213-24. PubMed ID: 15808407
[TBL] [Abstract][Full Text] [Related]
10. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
[TBL] [Abstract][Full Text] [Related]
11. CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation.
Alexandrov K; Cascorbi I; Rojas M; Bouvier G; Kriek E; Bartsch H
Carcinogenesis; 2002 Dec; 23(12):1969-77. PubMed ID: 12507920
[TBL] [Abstract][Full Text] [Related]
12. GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct levels.
Butkiewicz D; Cole KJ; Phillips DH; Harris CC; Chorazy M
Eur J Cancer Prev; 1999 Aug; 8(4):315-23. PubMed ID: 10493307
[TBL] [Abstract][Full Text] [Related]
13. Impact of adduct determination on the assessment of cancer susceptibility.
Bartsch H; Rojas M; Alexandrov K; Risch A
Recent Results Cancer Res; 1998; 154():86-96. PubMed ID: 10026994
[TBL] [Abstract][Full Text] [Related]
14. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo.
Kato S; Bowman ED; Harrington AM; Blomeke B; Shields PG
J Natl Cancer Inst; 1995 Jun; 87(12):902-7. PubMed ID: 7666479
[TBL] [Abstract][Full Text] [Related]
15. BPDE-DNA adduct formation and alterations of mRNA, protein, and DNA methylation of CYP1A1, GSTP1, and GSTM1 induced by benzo[a]pyrene and the intervention of aspirin in mice.
Liu A; Li X; Zhou L; Yan X; Xia N; Song Z; Cao J; Hao Z; Zhang Z; Liang R; Zhang H
Environ Sci Pollut Res Int; 2023 Oct; 30(48):106549-106561. PubMed ID: 37730975
[TBL] [Abstract][Full Text] [Related]
16. GSTM1 null genotype as a risk factor for anti-BPDE-DNA adduct formation in mononuclear white blood cells of coke-oven workers.
Pavanello S; Siwinska E; Mielzynska D; Clonfero E
Mutat Res; 2004 Mar; 558(1-2):53-62. PubMed ID: 15036119
[TBL] [Abstract][Full Text] [Related]
17. Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 MspI and GSTM1 genotypes in lung patients.
Schoket B; Phillips DH; Kostic S; Vincze I
Carcinogenesis; 1998 May; 19(5):841-6. PubMed ID: 9635872
[TBL] [Abstract][Full Text] [Related]
18. DNA adduct level in lung tissue may act as a risk biomarker of lung cancer.
Cheng YW; Chen CY; Lin P; Huang KH; Lin TS; Wu MH; Lee H
Eur J Cancer; 2000 Jul; 36(11):1381-8. PubMed ID: 10899651
[TBL] [Abstract][Full Text] [Related]
19. Influence of GSTM1 and NAT2 genotypes on placental DNA adducts in an environmentally exposed population.
Topinka J; Binková B; Mracková G; Stávková Z; Peterka V; Benes I; Dejmek J; Lenícek J; Pilcík T; Srám RJ
Environ Mol Mutagen; 1997; 30(2):184-95. PubMed ID: 9329643
[TBL] [Abstract][Full Text] [Related]
20. Polycyclic aromatic hydrocarbon-DNA adducts in lung tissue from lung cancer patients.
van Schooten FJ; Hillebrand MJ; van Leeuwen FE; Lutgerink JT; van Zandwijk N; Jansen HM; Kriek E
Carcinogenesis; 1990 Sep; 11(9):1677-81. PubMed ID: 2119262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
